IM Cannabis Corp.

We are an international cannabis company focused on the importation, distribution, and sale of medical cannabis products to medical patients in Israel and Germany. Following regulatory reforms in Germany on April 1, 2024, we shifted our focus and resources to the German cannabis market. We utilize a cross-border supply chain and distribution infrastructure. In Israel, we import, distribute, and sell cannabis to local medical patients through medical cannabis retail pharmacies, online platforms, a distribution center, and logistical hubs operated by IMC Holdings' subsidiaries, adhering to Israeli regulatory requirements. We also maintain proprietary genetics through third-party cultivation facilities in Israel and continue to offer medical cannabis products under our brands through strategic alliances with suppliers. Throughout 2024 and 2025, we implemented strategic measures in Israel to enhance operational efficiency, reduce costs, and improve business performance, including optimizing logistics and distribution, streamlining workforce and facilities, and adapting to geopolitical challenges. Key actions in 2024 and 2025 included engaging a new third-party processing facility, changing shipping and distribution service providers, reducing headcount, closing certain trading activities, and adjusting operations due to logistical disruptions from regional hostilities. We operate in the retail segment in Israel through IMC Holdings, holding two licensed pharmacies: Vironna, serving the Arab consumer segment, and Pharm Yarok, a large pharmacy in the Sharon plain area with a call center for deliveries. We also operate home-delivery services and an online retail platform under "Pharm Yarok," which includes a customer service center. On April 9, 2024, Pharm Yarok entered into a strategic distribution agreement with Vessel Brand Inc.